BioXell SpA
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 31 (Table of Contents)
Published: 2 Dec-2002
DOI: 10.3833/pdr.v2002.i31.971 ISSN: 1756-7874
Section: Company Profile
Fulltext:
Abstract
BioXell SpA is an R&D-based biopharmaceutical company, its core strategy is to discover and develop novel therapeutics targeting the immune system and controlling the causes of acute and chronic inflammatory diseases, treating infection and cancer...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS